Preparation of a Beverage Containing Freeze-Dried Watercress for a Clinical Trial of Carcinogen and Toxicant Detoxification

Melissa J L Bonorden, Steven G Carmella, Oliver T Ballinger, Jessica Williams, Irv Dorn, Hanna Vanderloo, Naomi Fujioka, Dorothy K Hatsukami, Stephen S Hecht

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

Watercress is an excellent source of phenethyl isothiocyanate (PEITC), shown in many studies to enhance carcinogen and toxicant detoxification and to inhibit carcinogenesis. Based on a previous observation that PEITC can enhance the detoxification of common environmental pollutants such as acrolein, crotonaldehyde, benzene, and 1,3-butadiene, we designed a clinical trial testing the hypothesis that daily consumption of a drink containing freeze-dried watercress, an abundant source of PEITC, would have a similar effect, particularly observed in subjects who were null in certain glutathione S-transferase genes. This manuscript describes the preparation of nearly 100 pounds of freeze-dried watercress for this trial, starting with laboratory-scale pilot studies and proceeding to industrial-scale production of the fully validated product in compliance with all food safety requirements. Initial results validating subject compliance in the clinical trial are also presented. PREVENTION RELEVANCE: This study describes the preparation of a beverage containing freeze-dried watercress suitable for consumption in a clinical trial to determine whether a constituent of this beverage-PEITC, which has cancer prevention properties-can enhance detoxification of common environmental carcinogens and toxicants such as benzene, which may have a role in environmentally induced cancer. See related Spotlight, p. 139.

Original languageEnglish (US)
Pages (from-to)143-150
Number of pages8
JournalCancer Prevention Research
Volume15
Issue number3
DOIs
StatePublished - Mar 1 2022

Bibliographical note

Funding Information:
S.S. Hecht, D.K. Hatsukami, S.G. Carmella, N. Fujioka, and H. Vanderloo report grants from NIH during the conduct of the study. I. Dorn reports other support from University of Minnesota during the conduct of the study. N. Fujioka reports grants from NIH during the conduct of the study; other support from Takeda; and other support from AstraZeneca/Medimmune outside the submitted work. No disclosures were reported by the other authors.

Funding Information:
This study was supported by grant R01 CA-222005 (to S.S. Hecht, S.G. Carmella, H. Vanderloo, and D.K. Hatsukami) from the NCI. This grant supported all expenses except the fresh watercress, which was kindly donated by B&W Quality Growers. We thank Viviana Paiano, M.S., for expert technical assistance.

Publisher Copyright:
© 2021 American Association for Cancer Research.

PubMed: MeSH publication types

  • Journal Article
  • Research Support, N.I.H., Extramural

Fingerprint

Dive into the research topics of 'Preparation of a Beverage Containing Freeze-Dried Watercress for a Clinical Trial of Carcinogen and Toxicant Detoxification'. Together they form a unique fingerprint.

Cite this